Keyphrases
United States
100%
Treatment Strategy
100%
Cryptococcal Meningitis
100%
Explosives
100%
Flucytosine
100%
Cost-effectiveness Analysis
100%
Amphotericin B
72%
Fluconazole
27%
Incremental Cost-effectiveness Ratio
18%
Cost Estimation
9%
Combination Therapy
9%
Monotherapy
9%
Randomized Trial
9%
Health Care Costs
9%
Cryptococcus
9%
Hospitalization
9%
Generic Drugs
9%
Treatment Costs
9%
United Kingdom
9%
Survival Data
9%
Survival Estimation
9%
Treatment Course
9%
Medication Cost
9%
Quality-adjusted Life Years
9%
Induction Regimen
9%
Alternative Regimens
9%
Access Issues
9%
Amphotericin B Deoxycholate
9%
US Guidelines
9%
Profiteering
9%
Drug Manufacturer
9%
Rising Prices
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cryptococcal Meningitis
100%
Flucytosine
100%
Amphotericin
63%
Fluconazole
27%
Pharmaceutical Manufacturing
9%
Amphotericin B Deoxycholate
9%
Generic Drug
9%
Combination Therapy
9%
Monotherapy
9%
Amphotericin B
9%